- Home
- SEPN
SEPN
SEPTERNA INC
as 07-11-2025 3:36pm EST
Stocks
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.
| Founded: | 2022 | Country: | United States |
| Employees: | N/A | City: | SOUTH SAN FRANCISCO |
| Market Cap: | 453.2M | IPO Year: | 2024 |
| Target Price: | $26.75 | AVG Volume (30 days): | 443.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.89 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.17 - $28.99 | Next Earning Date: | 08-15-2025 |
| Revenue: | $977,000 | Revenue Growth: | 108.76% |
| Revenue Growth (this year): | -62.17% | Revenue Growth (next year): | 526.96% |
Latest SEPTERNA INC News
SEPN Breaking Stock News: Dive into SEPN Ticker-Specific Updates for Smart Investing
GOBankingRates
a month ago
7 Luxury Vehicles Expected To Skyrocket in Price Due To Trump’s Tariffs
GOBankingRates
a month ago
3 International Vacations That Are Cheaper Than an iPhone
GOBankingRates
a month ago
Suze Orman’s 5 Best Tips for Saving Money Even When Living Paycheck to Paycheck
Yahoo Finance
a month ago
This week in Trumponomics: Too bad TACO isn’t true
The Guardian
a month ago
Starmer says Farage would spook the City and give us Truss 2 – he could be right
Yahoo Finance Video
a month ago
AI ecosystem isn't just Nvidia: Unlock it further with this ETF
Benzinga
a month ago
Is Dave Ramsey's Home Buying Advice Realistic For The Average Homeowner?
Reuters
a month ago
Ford recalls more than 29,000 vehicles in the US, NHTSA says
Compare SEPN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SEPN SEPTERNA INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.